share_log

Versus Systems Analyst Ratings

Benzinga Analyst Ratings ·  Aug 19, 2022 07:14
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/19/2022 281.68% HC Wainwright & Co. $2.5 → $1.5 Maintains Buy
04/29/2022 536.13% HC Wainwright & Co. $3.5 → $2.5 Maintains Buy
03/18/2022 790.59% HC Wainwright & Co. $5 → $3.5 Maintains Buy
11/23/2021 1172.26% HC Wainwright & Co. $7 → $5 Maintains Buy
07/07/2021 1681.17% HC Wainwright & Co. → $7 Initiates Coverage On → Buy

Versus Systems Questions & Answers

What is the target price for Versus Systems (VS)?

The latest price target for Versus Systems (NASDAQ: VS) was reported by HC Wainwright & Co. on August 19, 2022. The analyst firm set a price target for $1.50 expecting VS to rise to within 12 months (a possible 281.68% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Versus Systems (VS)?

The latest analyst rating for Versus Systems (NASDAQ: VS) was provided by HC Wainwright & Co., and Versus Systems maintained their buy rating.

When is the next analyst rating going to be posted or updated for Versus Systems (VS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Versus Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Versus Systems was filed on August 19, 2022 so you should expect the next rating to be made available sometime around August 19, 2023.

Is the Analyst Rating Versus Systems (VS) correct?

While ratings are subjective and will change, the latest Versus Systems (VS) rating was a maintained with a price target of $2.50 to $1.50. The current price Versus Systems (VS) is trading at is $0.39, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment